R. Hawks

1.2k total citations
26 papers, 845 citations indexed

About

R. Hawks is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R. Hawks has authored 26 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R. Hawks's work include Hematopoietic Stem Cell Transplantation (15 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (7 papers). R. Hawks is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (7 papers). R. Hawks collaborates with scholars based in United States, Poland and India. R. Hawks's co-authors include Janice Post‐White, Monica Bhatia, Mitchell S. Cairo, James H. Garvin, Joseph E. Schwartz, Elena J. Ladas, Prakash Satwani, G. Del Toro, Janice S. Withycombe and Nita L. Seibel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

R. Hawks

26 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Hawks United States 14 340 304 234 230 162 26 845
Steven J. Culbert United States 17 269 0.8× 182 0.6× 240 1.0× 118 0.5× 306 1.9× 38 898
L Wranne Sweden 15 141 0.4× 322 1.1× 205 0.9× 150 0.7× 39 0.2× 42 859
Rajni Agarwal United States 16 214 0.6× 104 0.3× 80 0.3× 119 0.5× 156 1.0× 47 819
Angela R. Smith United States 16 366 1.1× 196 0.6× 141 0.6× 78 0.3× 66 0.4× 39 673
A.M.Z. Chang Hong Kong 17 51 0.1× 397 1.3× 88 0.4× 195 0.8× 96 0.6× 35 923
Marie‐Hélène Odièvre France 14 277 0.8× 95 0.3× 17 0.1× 266 1.2× 27 0.2× 46 830
Özlem Tüfekçi Türkiye 12 76 0.2× 95 0.3× 73 0.3× 59 0.3× 48 0.3× 51 334
Alison Chu United States 15 99 0.3× 296 1.0× 65 0.3× 145 0.6× 13 0.1× 61 740
AM Yeager United States 17 565 1.7× 87 0.3× 146 0.6× 196 0.9× 276 1.7× 21 1.0k
Stephanie Allen United Kingdom 16 33 0.1× 653 2.1× 90 0.4× 325 1.4× 44 0.3× 43 1.1k

Countries citing papers authored by R. Hawks

Since Specialization
Citations

This map shows the geographic impact of R. Hawks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hawks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hawks more than expected).

Fields of papers citing papers by R. Hawks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hawks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hawks. The network helps show where R. Hawks may publish in the future.

Co-authorship network of co-authors of R. Hawks

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hawks. A scholar is included among the top collaborators of R. Hawks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hawks. R. Hawks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ladas, Elena J., Monica Bhatia, Lu Chen, et al.. (2015). The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplantation. 51(2). 262–266. 95 indexed citations
2.
Bhatia, Monica, Zhezhen Jin, Claire E. Baker, et al.. (2014). Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplantation. 49(7). 913–920. 75 indexed citations
3.
Satwani, Prakash, Zhezhen Jin, Erin Morris, et al.. (2012). Transplantation-Related Mortality, Graft Failure, and Survival after Reduced-Toxicity Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation in 100 Consecutive Pediatric Recipients. Biology of Blood and Marrow Transplantation. 19(4). 552–561. 55 indexed citations
4.
5.
Withycombe, Janice S., Janice Post‐White, Jane L. Meza, et al.. (2009). Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961. Pediatric Blood & Cancer. 53(7). 1249–1254. 99 indexed citations
6.
Waxman, Ian M., Olga Militano, Erin Morris, et al.. (2008). Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning†. Pediatric Transplantation. 13(4). 464–474. 18 indexed citations
7.
8.
Bradley, M.B., Prakash Satwani, Erin Morris, et al.. (2007). Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplantation. 40(7). 621–631. 60 indexed citations
9.
Yen, Catherine, Lisa Saiman, Diane George, et al.. (2006). A Low Incidence of Nontuberculous Mycobacterial Infections in Pediatric Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 12(11). 1188–1197. 19 indexed citations
10.
Ladas, Elena J., et al.. (2006). Evidence for Symptom Management in the Child With Cancer. Journal of Pediatric Hematology/Oncology. 28(9). 601–615. 37 indexed citations
11.
Post‐White, Janice, R. Hawks, Ann M. O’Mara, & Mary Jane Ott. (2006). Future Directions of CAM Research in Pediatric Oncology. Journal of Pediatric Oncology Nursing. 23(5). 265–268. 13 indexed citations
12.
Satwani, Prakash, G. Del Toro, M.B. Bradley, et al.. (2006). 3: Reduced Intensity (RI) aLlogeneic Cord Blood Hematopoietic Cell Transplantation (Allo-CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases. Biology of Blood and Marrow Transplantation. 12(11). 1218–1218. 3 indexed citations
13.
14.
15.
Hawks, R.. (2006). Complementary and Alternative Medicine Research Initiatives in the Children’s Oncology Group and the Role of the Pediatric Oncology Nurse. Journal of Pediatric Oncology Nursing. 23(5). 261–264. 6 indexed citations
16.
Post‐White, Janice & R. Hawks. (2005). Complementary and Alternative Medicine in Pediatric Oncology. Seminars in Oncology Nursing. 21(2). 107–114. 19 indexed citations
17.
Toro, G. Del, M.B. Bradley, Prakash Satwani, et al.. (2005). Reduced Intensity (RI) Allogeneic Cord Blood Hematopoietic Cell Transplantation (Allo CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases.. Blood. 106(11). 5463–5463. 5 indexed citations
18.
Styczyński, Jan, James H. Garvin, David G. Savage, et al.. (2004). Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplantation. 34(2). 129–136. 35 indexed citations
19.
Bradley, M.B., Lauren Harrison, Erin Cooney, et al.. (2004). Reduced Intensity (RI) Allogeneic Stem Cell Transplantation (ALLOSCT) with Umbilical Cord Blood (UCB) in Pediatric Patients with Malignant and Non-Malignant Diseases.. Blood. 104(11). 5167–5167. 1 indexed citations
20.
Fetell, Michael R., Linda T. Vahdat, T. J. Garrett, et al.. (1998). High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplantation. 22(7). 661–667. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven J. Culbert Breakdown of academic impact, for papers by L Wranne Breakdown of academic impact, for papers by Rajni Agarwal Breakdown of academic impact, for papers by Angela R. Smith Breakdown of academic impact, for papers by A.M.Z. Chang Breakdown of academic impact, for papers by Marie‐Hélène Odièvre Breakdown of academic impact, for papers by Özlem Tüfekçi Breakdown of academic impact, for papers by Alison Chu Breakdown of academic impact, for papers by AM Yeager Breakdown of academic impact, for papers by Stephanie Allen
Rankless by CCL
2026